These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Autoantiidiotypic antibodies in myasthenia gravis. Lefvert AK; Holm G; Pirskanen R Ann N Y Acad Sci; 1987; 505():133-54. PubMed ID: 3500664 [No Abstract] [Full Text] [Related]
23. Autoimmunity of thyroid disease. With emphasis on Graves' disease. van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065 [No Abstract] [Full Text] [Related]
24. Anti-nicotinic receptor autoimmunity in myasthenia gravis. Establishment of specific T-helper cell lines and identification of sensitizing epitopes on the alpha-subunit. Hohlfeld R; Toyka K; Heininger K; Tzartos SJ; Walgrave SL; Protti P; Conti-Tronconi BM Monogr Allergy; 1988; 25():50-67. PubMed ID: 2459613 [No Abstract] [Full Text] [Related]
25. The auto-anti-idiotypic route to antireceptor antibodies. Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Wan KK; Sarangarajan R; Penn AS Ann N Y Acad Sci; 1986; 475():219-26. PubMed ID: 3491562 [No Abstract] [Full Text] [Related]
26. A possible cause of myasthenia gravis: idiotypic networks involving bacterial antigens. Dwyer DS; Vakil M; Bradley RJ; Oh SJ; Kearney JF Ann N Y Acad Sci; 1987; 505():461-71. PubMed ID: 2446558 [No Abstract] [Full Text] [Related]
27. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera. Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552 [No Abstract] [Full Text] [Related]
28. Autoimmune diseases against cell surface receptors: myasthenia gravis, a prototype anti-receptor disease. De Baets MH Neth J Med; 1994 Dec; 45(6):294-301. PubMed ID: 7838246 [TBL] [Abstract][Full Text] [Related]
29. [Extention of the concept of antireceptor autoantibody disease]. Bach JF; Morel E Nouv Presse Med; 1982 May; 11(24):1845-7. PubMed ID: 6287407 [No Abstract] [Full Text] [Related]
30. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis. Kawanami S; Tsuji R; Oda K Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620 [TBL] [Abstract][Full Text] [Related]
31. Autoimmune endocrine diseases. De Baets MH Year Immunol; 1989; 4():264-75. PubMed ID: 2564710 [No Abstract] [Full Text] [Related]
32. [Autoimmunological and allergic disorders with Hashimoto and Graves disease]. Przybylik-Mazurek E; Kotlinowska B; Kasztelnik M; Stefańska A; Huszno B Przegl Lek; 2006; 63(9):719-22. PubMed ID: 17479856 [TBL] [Abstract][Full Text] [Related]
33. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases. Nossal GJ Ann N Y Acad Sci; 1987; 505():610-8. PubMed ID: 3500669 [No Abstract] [Full Text] [Related]
34. Thyrotropin receptor antibodies in parotid saliva. Tumilasci OR; Arqueros MC; Ostuni MA; el Tamer E; Houssay AB J Endocrinol Invest; 1996; 19(7):412-4. PubMed ID: 8884533 [TBL] [Abstract][Full Text] [Related]
35. Antibodies against beta1 and beta2 adrenergic receptors in myasthenia gravis. Xu BY; Pirskanen R; Lefvert AK J Neuroimmunol; 1998 Nov; 91(1-2):82-8. PubMed ID: 9846822 [TBL] [Abstract][Full Text] [Related]
36. [Autoantibodies in Myasthenia Gravis]. Higuchi O Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289 [TBL] [Abstract][Full Text] [Related]